World

Top 413 largest Companies in the Drug Manufacturers—Specialty & Generic industry in the World by Market Cap

This is the list of the largest public listed companies in the Drug Manufacturers—Specialty & Generic industry in the world by market capitalization with links to their reference stock.

World Drug Manufacturers—Specialty & Generic Industry Analysis
World Top Companies World Companies Analysis

Top Drug Manufacturers—Specialty & Generic Companies in the World as of Jul. 01, 2025

Rank Company Market Cap (USD) Country Sector Industry
121 PolyPeptide Group AG $876.3 M Switzerland Swiss Healthcare Swiss Drug Manufacturers—Specialty & Generic
122 Avadel Pharmaceuticals plc $865.3 M Ireland Irish Healthcare Irish Drug Manufacturers—Specialty & Generic
123 Radius Health, Inc. $840.1 M United States US Healthcare US Drug Manufacturers—Specialty & Generic
124 Chong Kun Dang Pharmaceutical Corp $838.4 M South Korea South Korean Healthcare South Korean Drug Manufacturers—Specialty & Generic
125 Saudi Pharmaceutical Industries and Medical Appliances Corp $835.8 M Saudi Arabia Saudi Arabian Healthcare Saudi Arabian Drug Manufacturers—Specialty & Generic
126 Jianmin Pharmaceutical Group Co. Ltd $835.7 M China Chinese Healthcare Chinese Drug Manufacturers—Specialty & Generic
127 JiangsuJibeier Pharmaceutical Co. Ltd $816.7 M China Chinese Healthcare Chinese Drug Manufacturers—Specialty & Generic
128 China Shineway Pharmaceutical Group Ltd $796.8 M China Chinese Healthcare Chinese Drug Manufacturers—Specialty & Generic
129 Cronos Group Inc. $781.1 M Canada Canadian Healthcare Canadian Drug Manufacturers—Specialty & Generic
130 Ningbo Menovo Pharmaceutical Co. Ltd $780.9 M China Chinese Healthcare Chinese Drug Manufacturers—Specialty & Generic
131 Tibet Weixinkang Medicine Co. Ltd $770.2 M China Chinese Healthcare Chinese Drug Manufacturers—Specialty & Generic
132 Aerie Pharmaceuticals, Inc. $753.6 M

(Nov. 1, 2022)

United States US Healthcare US Drug Manufacturers—Specialty & Generic
133 Aker BioMarine AS $738.8 M

(July 1, 2024)

Norway Norway Healthcare Norway Drug Manufacturers—Specialty & Generic
134 Trulieve Cannabis Corp $735.6 M United States US Healthcare US Drug Manufacturers—Specialty & Generic
135 Fuan Pharmaceutical $724.0 M China Chinese Healthcare Chinese Drug Manufacturers—Specialty & Generic
136 Mega Lifesciences Public Company Ltd $719.6 M Thailand Thai Healthcare Thai Drug Manufacturers—Specialty & Generic
137 Mochida Pharmaceutical Co. Ltd $717.2 M Japan Japanese Healthcare Japanese Drug Manufacturers—Specialty & Generic
138 Swedencare AB $700.8 M Sweden Swedish Healthcare Swedish Drug Manufacturers—Specialty & Generic
139 Beijing Beilu Pharmaceutical Co. Ltd $692.0 M China Chinese Healthcare Chinese Drug Manufacturers—Specialty & Generic
140 PetIQ, Inc. $675.7 M

(July 1, 2024)

United States US Healthcare US Drug Manufacturers—Specialty & Generic
141 Tianjin Tianyao Pharmaceuticals Co. Ltd $664.5 M China Chinese Healthcare Chinese Drug Manufacturers—Specialty & Generic
142 Shanxi Zhendong Pharmaceutical Co.,Ltd $653.9 M China Chinese Healthcare Chinese Drug Manufacturers—Specialty & Generic
143 Nihon Chouzai Co.,Ltd. $653.2 M Japan Japanese Healthcare Japanese Drug Manufacturers—Specialty & Generic
144 Nanjing Hicin Pharmaceutical Co. Ltd $652.6 M China Chinese Healthcare Chinese Drug Manufacturers—Specialty & Generic
145 TTY Biopharm Company Ltd $641.0 M Taiwan Taiwanese Healthcare Taiwanese Drug Manufacturers—Specialty & Generic
146 Elite Pharmaceuticals, Inc. $641.0 M United States US Healthcare US Drug Manufacturers—Specialty & Generic
147 Hunan Fangsheng Pharmaceutical Co. Ltd $633.1 M China Chinese Healthcare Chinese Drug Manufacturers—Specialty & Generic
148 Grape King Bio Ltd $632.3 M Taiwan Taiwanese Healthcare Taiwanese Drug Manufacturers—Specialty & Generic
149 Nanjing Well Pharmaceutical Group Co.,Ltd. $630.3 M China Chinese Healthcare Chinese Drug Manufacturers—Specialty & Generic
150 Curaleaf Holdings, Inc. $629.5 M United States US Healthcare US Drug Manufacturers—Specialty & Generic

Top Drug Manufacturers—Specialty & Generic Companies in the World as of Jul. 01, 2025

121. PolyPeptide Group AG

Company Profile: PolyPeptide Group AG
Market Cap (USD): $876.3 M
Country: Switzerland
Sector: Swiss Healthcare
Industry: Swiss Drug Manufacturers—Specialty & Generic

122. Avadel Pharmaceuticals plc

Company Profile: Avadel Pharmaceuticals plc
Market Cap (USD): $865.3 M
Country: Ireland
Sector: Irish Healthcare
Industry: Irish Drug Manufacturers—Specialty & Generic

123. Radius Health, Inc.

Company Profile: Radius Health, Inc.
Market Cap (USD): $840.1 M
Country: United States
Sector: US Healthcare
Industry: US Drug Manufacturers—Specialty & Generic

124. Chong Kun Dang Pharmaceutical Corp

Company Profile: Chong Kun Dang Pharmaceutical Corp
Market Cap (USD): $838.4 M
Country: South Korea
Sector: South Korean Healthcare
Industry: South Korean Drug Manufacturers—Specialty & Generic

125. Saudi Pharmaceutical Industries and Medical Appliances Corp

Company Profile: Saudi Pharmaceutical Industries and Medical Appliances Corp
Market Cap (USD): $835.8 M
Country: Saudi Arabia
Sector: Saudi Arabian Healthcare
Industry: Saudi Arabian Drug Manufacturers—Specialty & Generic

126. Jianmin Pharmaceutical Group Co. Ltd

Company Profile: Jianmin Pharmaceutical Group Co. Ltd
Market Cap (USD): $835.7 M
Country: China
Sector: Chinese Healthcare
Industry: Chinese Drug Manufacturers—Specialty & Generic

127. JiangsuJibeier Pharmaceutical Co. Ltd

Company Profile: JiangsuJibeier Pharmaceutical Co. Ltd
Market Cap (USD): $816.7 M
Country: China
Sector: Chinese Healthcare
Industry: Chinese Drug Manufacturers—Specialty & Generic

128. China Shineway Pharmaceutical Group Ltd

Company Profile: China Shineway Pharmaceutical Group Ltd
Market Cap (USD): $796.8 M
Country: China
Sector: Chinese Healthcare
Industry: Chinese Drug Manufacturers—Specialty & Generic

129. Cronos Group Inc.

Company Profile: Cronos Group Inc.
Market Cap (USD): $781.1 M
Country: Canada
Sector: Canadian Healthcare
Industry: Canadian Drug Manufacturers—Specialty & Generic

130. Ningbo Menovo Pharmaceutical Co. Ltd

Company Profile: Ningbo Menovo Pharmaceutical Co. Ltd
Market Cap (USD): $780.9 M
Country: China
Sector: Chinese Healthcare
Industry: Chinese Drug Manufacturers—Specialty & Generic

131. Tibet Weixinkang Medicine Co. Ltd

Company Profile: Tibet Weixinkang Medicine Co. Ltd
Market Cap (USD): $770.2 M
Country: China
Sector: Chinese Healthcare
Industry: Chinese Drug Manufacturers—Specialty & Generic

132. Aerie Pharmaceuticals, Inc.

Company Profile: Aerie Pharmaceuticals, Inc.
Market Cap (USD): $753.6 M (Nov. 1, 2022)
Country: United States
Sector: US Healthcare
Industry: US Drug Manufacturers—Specialty & Generic

133. Aker BioMarine AS

Company Profile: Aker BioMarine AS
Market Cap (USD): $738.8 M (July 1, 2024)
Country: Norway
Sector: Norway Healthcare
Industry: Norway Drug Manufacturers—Specialty & Generic

134. Trulieve Cannabis Corp

Company Profile: Trulieve Cannabis Corp
Market Cap (USD): $735.6 M
Country: United States
Sector: US Healthcare
Industry: US Drug Manufacturers—Specialty & Generic

135. Fuan Pharmaceutical

Company Profile: Fuan Pharmaceutical
Market Cap (USD): $724.0 M
Country: China
Sector: Chinese Healthcare
Industry: Chinese Drug Manufacturers—Specialty & Generic

136. Mega Lifesciences Public Company Ltd

Company Profile: Mega Lifesciences Public Company Ltd
Market Cap (USD): $719.6 M
Country: Thailand
Sector: Thai Healthcare
Industry: Thai Drug Manufacturers—Specialty & Generic

137. Mochida Pharmaceutical Co. Ltd

Company Profile: Mochida Pharmaceutical Co. Ltd
Market Cap (USD): $717.2 M
Country: Japan
Sector: Japanese Healthcare
Industry: Japanese Drug Manufacturers—Specialty & Generic

138. Swedencare AB

Company Profile: Swedencare AB
Market Cap (USD): $700.8 M
Country: Sweden
Sector: Swedish Healthcare
Industry: Swedish Drug Manufacturers—Specialty & Generic

139. Beijing Beilu Pharmaceutical Co. Ltd

Company Profile: Beijing Beilu Pharmaceutical Co. Ltd
Market Cap (USD): $692.0 M
Country: China
Sector: Chinese Healthcare
Industry: Chinese Drug Manufacturers—Specialty & Generic

140. PetIQ, Inc.

Company Profile: PetIQ, Inc.
Market Cap (USD): $675.7 M (July 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Drug Manufacturers—Specialty & Generic

141. Tianjin Tianyao Pharmaceuticals Co. Ltd

Company Profile: Tianjin Tianyao Pharmaceuticals Co. Ltd
Market Cap (USD): $664.5 M
Country: China
Sector: Chinese Healthcare
Industry: Chinese Drug Manufacturers—Specialty & Generic

142. Shanxi Zhendong Pharmaceutical Co.,Ltd

Company Profile: Shanxi Zhendong Pharmaceutical Co.,Ltd
Market Cap (USD): $653.9 M
Country: China
Sector: Chinese Healthcare
Industry: Chinese Drug Manufacturers—Specialty & Generic

143. Nihon Chouzai Co.,Ltd.

Company Profile: Nihon Chouzai Co.,Ltd.
Market Cap (USD): $653.2 M
Country: Japan
Sector: Japanese Healthcare
Industry: Japanese Drug Manufacturers—Specialty & Generic

144. Nanjing Hicin Pharmaceutical Co. Ltd

Company Profile: Nanjing Hicin Pharmaceutical Co. Ltd
Market Cap (USD): $652.6 M
Country: China
Sector: Chinese Healthcare
Industry: Chinese Drug Manufacturers—Specialty & Generic

145. TTY Biopharm Company Ltd

Company Profile: TTY Biopharm Company Ltd
Market Cap (USD): $641.0 M
Country: Taiwan
Sector: Taiwanese Healthcare
Industry: Taiwanese Drug Manufacturers—Specialty & Generic

146. Elite Pharmaceuticals, Inc.

Company Profile: Elite Pharmaceuticals, Inc.
Market Cap (USD): $641.0 M
Country: United States
Sector: US Healthcare
Industry: US Drug Manufacturers—Specialty & Generic

147. Hunan Fangsheng Pharmaceutical Co. Ltd

Company Profile: Hunan Fangsheng Pharmaceutical Co. Ltd
Market Cap (USD): $633.1 M
Country: China
Sector: Chinese Healthcare
Industry: Chinese Drug Manufacturers—Specialty & Generic

148. Grape King Bio Ltd

Company Profile: Grape King Bio Ltd
Market Cap (USD): $632.3 M
Country: Taiwan
Sector: Taiwanese Healthcare
Industry: Taiwanese Drug Manufacturers—Specialty & Generic

149. Nanjing Well Pharmaceutical Group Co.,Ltd.

Company Profile: Nanjing Well Pharmaceutical Group Co.,Ltd.
Market Cap (USD): $630.3 M
Country: China
Sector: Chinese Healthcare
Industry: Chinese Drug Manufacturers—Specialty & Generic

150. Curaleaf Holdings, Inc.

Company Profile: Curaleaf Holdings, Inc.
Market Cap (USD): $629.5 M
Country: United States
Sector: US Healthcare
Industry: US Drug Manufacturers—Specialty & Generic

Stay in touch